Ticker
ABCLCompany Name
ABCELLERA BIOLOGICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
---|---|---|---|
6/30/2025 | $ 1.29B | 0 | $ -138.99M |
3/31/2025 | $ 478.9M | 0 | $ -143.29M |
12/31/2024 | $ 749.54M | 0 | $ -186.95M |
9/30/2024 | $ 768.24M | 0 | $ -197.36M |
6/30/2024 | $ 732.94M | 0 | $ -170.4M |
3/31/2024 | $ 1.11B | 0 | $ -127.63M |
12/31/2023 | $ 1.47B | 0 | $ -120.82M |
9/30/2023 | $ 1.16B | 0 | $ -68.2M |
6/30/2023 | $ 1.89B | 0 | $ -187.06M |
3/31/2023 | $ 1.77B | 28.54 | $ 61.93M |
EV / FCF
(=) EV/FCF
EV/FCF for ABCELLERA BIOLOGICS INC is calculated as follows: EV [ $ 0 ] / FCF [ $ -1.3M ]
(=) EV/FCF [ 0 ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.2K |
---|---|
min | 0.05 |
max | 77.98 |
average | 23.46 |
median | 19.08 |
std | 16.15 |